Michael Schaufele, MD
Physical Medicine & Rehabilitation · Atlanta, GANPI 1639271331
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,060 of the $19,782 with a category attached, or 71.1%. Relievant Medsystems, Inc. accounts for 74.8% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2021 at $10,504 and has fallen 98.1% since, to $204 in 2025. Among physical medicine & rehabilitation clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $111.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$15K
- Nevro Corp.$2K
- Abbott$903
- Medtronic$461
- Globus Medical$186
- SPR Therapeutics, Inc$185
- plus $1K from 26 others
Across 11 payments — averaging $14,499 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Relievant Medsystems, Inc.$159K
What the payments were for
- Consulting fees$14,06071%
- Travel & lodging$5793%
- Food & beverage$5,07026%
- Education$730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 19 | $14,801 |
| Nevro Corp. | 40 | $1,778 |
| Abbott | 21 | $903 |
| Medtronic(2 entities) | 11 | $461 |
| Globus Medical | 4 | $186 |
| SPR Therapeutics, Inc | 3 | $185 |
| Biodelivery Sciences International, Inc. | 4 | $153 |
| Amgen(2 entities) | 3 | $147 |
| Arbor Pharmaceuticals, Inc. | 10 | $129 |
| Collegium Pharmaceutical, Inc. | 9 | $124 |
| Si-bone, Inc. | 1 | $94 |
| Eisai Inc. | 6 | $89 |
| Pacira Therapeutics, Inc. | 7 | $85 |
| Redhill Biopharma Inc. | 5 | $84 |
| Forte Bio-pharma LLC | 2 | $64 |
| Pfizer | 5 | $59 |
| Boston Scientific | 3 | $56 |
| Almatica Pharma LLC | 3 | $48 |
| Scilex Pharmaceuticals Inc. | 2 | $39 |
| Novartis | 3 | $34 |
| Painteq LLC | 1 | $33 |
| Baudax Bio Inc. | 2 | $31 |
| Daiichi Sankyo Inc. | 2 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Sentynl Therapeutics, Inc. | 2 | $26 |
| Kaleo, Inc. | 2 | $23 |
| Vertiflex, Inc. | 1 | $23 |
| Trevena, Inc. | 1 | $15 |
| AbbVie | 1 | $14 |
| Merck | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Assertio Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$28,483
- Senza$693
- Proclaim Family of SCS IPGs$422
- Omnia$400
- INTELLIS ADAPTIVESTIM$175
- SPRINT PNS System$149
- BELBUCA$125
- AIMOVIG$115
How this compares
$19,782 in reported general payments places this provider in the 95th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 153 | $1,648 |
| Celecoxib | 41 | $698 |
| Diclofenac Sodium | 72 | $683 |
| Pregabalin | 46 | $677 |
| Duloxetine Hcl | 50 | $498 |
| Meloxicam | 111 | $383 |
| Tramadol Hcl | 76 | $354 |
| Methylprednisolone | 51 | $335 |
| Methocarbamol | 23 | $158 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $109 |
| Tizanidine Hcl | 20 | $104 |
| Cyclobenzaprine Hcl | 14 | $92 |
| Naproxen | 18 | $41 |
| Lorazepam | 11 | $7 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Atlanta
- Erik ShawAtlanta$175K
- Abana AzariahAtlanta$22K
- Gerald BilskyAtlanta$16K
- Malcolm CarsonAtlanta$9K
- Michael ChuAtlanta$7K
- Michael YochelsonAtlanta$7K
- Derick DavisAtlanta$6K
- Ashish KhannaAtlanta$6K
- Robert GodsallAtlanta$4K
- Robert MaldonadoAtlanta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.